Comparing PECS2 block to intrathecal morphine for post-operative pain management
Ultrasound-guided PECS2 (The Pectoralis) Block Versus Intrathecal Morphine for Postoperative Analgesia After Mastectomy
NA · Sohag University · NCT06016205
This study is testing whether a new nerve block technique can help manage pain after breast surgery better than traditional morphine injections for patients undergoing a Modified Radical Mastectomy.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Sohag University (other) |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06016205 on ClinicalTrials.gov |
What this trial studies
This clinical trial involves 50 patients aged 18 to 60, scheduled for Modified Radical Mastectomy surgery, who will be randomly assigned to receive either an intrathecal morphine injection or a PECS2 block with bupivacaine. The PECS2 block is performed using ultrasound guidance to target specific nerves for pain relief. The study aims to evaluate the effectiveness of these two pain management techniques in reducing post-operative pain. Data will be collected by blinded anesthesiologists to ensure objectivity in assessing outcomes.
Who should consider this trial
Good fit: Ideal candidates are ASA grade I to II patients aged 18 to 60 scheduled for Modified Radical Mastectomy.
Not a fit: Patients with significant neurological, psychiatric, or neuromuscular diseases, or those who are pregnant or lactating, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective pain management option for patients undergoing surgery.
How similar studies have performed: Previous studies have shown promising results with similar nerve block techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) grade I to II, 18 to 60 years of age scheduled for Modified Radical Mastectomy surgery. Exclusion Criteria: * - Patient refusal. * Patient with significant neurological , psychiatric or neuromuscular disease * Alcoholism. Drug abuse. * Pregnancy or lactating women. * Suspected Coagulopathy. * Morbid obesity. * Known allergy to study medications. * local infection at the block site
Where this trial is running
Sohag
- Sohag University — Sohag, Egypt (RECRUITING)
Study contacts
- Study coordinator: Mohammed Ahmed Mahmoud, MD
- Email: mohamedmahmoud@med.sohag.edu.eg
- Phone: 01091328413
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Post-operative Pain